Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease

Advances in Chronic Kidney Disease
Peter A McCullough

Abstract

Cardiovascular disease accounts for the majority of morbidity and mortality in patients with end-stage renal disease (ESRD). Studies have identified several explanations for this observation, such as high rates of cardiovascular risk factors, lesser use of cardioprotective strategies, adverse outcomes with cardiovascular drugs and procedures, and accelerated atherosclerosis and myocardial disease in ESRD. Based on these findings, this article addresses the critical opportunities for improvement in cardiovascular outcomes in patients with ESRD. These improvements include prevention of cardiovascular events, management of acute coronary syndromes and heart failure, and the prevention of sudden death.

References

Jan 10, 1993·The New England Journal of Medicine·R L ConverseR G Victor
Jul 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J F Winchester
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·N L Benowitz
Apr 3, 1997·The New England Journal of Medicine·P M RidkerC H Hennekens
Nov 14, 1997·Journal of the American Society of Nephrology : JASN·D V VlahakosS Geroulanos
Dec 31, 1997·The New England Journal of Medicine·UNKNOWN Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
Jun 11, 1998·Journal of the American Society of Nephrology : JASN·K AmannG Mall
Sep 17, 1998·The New England Journal of Medicine·C A HerzogA J Collins
Jul 21, 1999·Kidney International. Supplement·H Oda, W F Keane
Jun 8, 2000·Renal Failure·A S NarulaR P Sapru
Sep 6, 2000·International Journal of Experimental Pathology·R Michael Pittilo
Sep 27, 2000·Journal of Thrombosis and Thrombolysis·J S KaufmanG Perdriset
Feb 13, 2001·Kidney International. Supplement·C van GuldenerC D Stehouwer
Feb 15, 2001·Seminars in Nephrology·A G Kocheril
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 21, 2001·JAMA : the Journal of the American Medical Association·L Y AgodoaUNKNOWN African American Study of Kidney Disease and Hypertension (AASK) Study Group
Jun 28, 2001·Archives of Internal Medicine·R Toto
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
Sep 29, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D SheminJ Selhub
Oct 5, 2001·Journal of the American College of Cardiology·A Al-AhmadM J Sarnak
Oct 17, 2001·Circulation·A C SchoolwerthUNKNOWN Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Assoc
Dec 18, 2001·Medicinal Research Reviews·Michele BuemiNicola Frisina
Jan 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gerard M London
Mar 22, 2002·The New England Journal of Medicine·Arthur J MossUNKNOWN Multicenter Automatic Defibrillator Implantation Trial II Investigators
Aug 15, 2002·American Heart Journal·Peter A McCulloughHarold J Manley
Dec 19, 2002·Drugs·Gillian M Keating, Karen L Goa
Dec 28, 2002·Diabetes Care·UNKNOWN American Diabetes Association
Feb 4, 2003·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Peter A McCulloughMichael P Hudson
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Peter A McCulloughUNKNOWN Breathing Not Properly Multinational Study Investigators
Mar 12, 2003·Journal of the American College of Cardiology·Peter A McCullough
Apr 16, 2003·Kidney International. Supplement·Wolfgang Koenig
Apr 16, 2003·Kidney International. Supplement·Charles A Herzog
Apr 16, 2003·The American Journal of the Medical Sciences·Brian D Schreiber
May 14, 2003·Journal of the American College of Cardiology·Gennaro CiceRaffaele Calabrò
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee

❮ Previous
Next ❯

Citations

Dec 3, 2014·The American Journal of Cardiology·Peter Andrew McCullough, William Clifford Roberts
May 11, 2005·Kidney International. Supplement·Peter A McCullough
Dec 1, 2006·The American Journal of Cardiology·Gabriel VorobiofScott McNitt
Jan 15, 2016·Clinical Journal of the American Society of Nephrology : CJASN·David M CharytanUNKNOWN MiD Investigators and Committees
Oct 25, 2017·Blood Purification·Claudio RoncoPeter A McCullough
Jun 13, 2009·Journal of Immigrant and Minority Health·Arijit NandiSandro Galea
Oct 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·M K RheeL S Phillips
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Peter A McCullough
Apr 12, 2007·Transplant International : Official Journal of the European Society for Organ Transplantation·Donatella CiuffredaManuel Pascual
Nov 2, 2016·The Cochrane Database of Systematic Reviews·Fang HuaChunjie Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.